|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nuckols TK, Anderson L, Popescu I, Diamant
AL, Doyle B, Di Capua P and Chou R: Opioid prescribing: A
systematic review and critical appraisal of guidelines for chronic
pain. Ann Intern Med. 160:38–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mercadante S: Fentanyl buccal tablet for
the treatment of cancer-related breakthrough pain. Expert Rev Clin
Pharmacol. 8:9–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qin Y, Li L, Chen J, Tang X, Liao C, Xie Y
and Xiao Q: Fentanyl inhibits progression of human gastric cancer
MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in
vitro. Oncol Res. 20:61–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nomura Y, Kawaraguchi Y, Sugimoto H,
Furuya H and Kawaguchi M: Effects of morphine and fentanyl on
5-fluorouracil sensitivity in human colon cancer HCT116 cells. J
Anesth. 28:298–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang XL, Chen ML and Zhou SL: Fentanyl
inhibits proliferation and invasion of colorectal cancer via
β-catenin. Int J Clin Exp Pathol. 8:227–235. 2015.PubMed/NCBI
|
|
9
|
Li AX, Xin WQ and Ma CG: Fentanyl inhibits
the invasion and migration of colorectal cancer cells via
inhibiting the negative regulation of Ets-1 on BANCR. Biochem
Biophys Res Commun. 465:594–600. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miao J, Wang L, Chen L, Yang T, Jin L and
Lin L: Fentanyl inhibits cell viability in human pancreatic cancer
cell line and tumor growth in pancreatic cancer cell-transplanted
mice. Int J Clin Exp Med. 8:17684–17693. 2015.PubMed/NCBI
|
|
11
|
Ohtsuka M, Ling H, Doki Y, Mori M and
Calin GA: MicroRNA processing and human cancer. J Clin Med.
4:1651–1667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang M, Zhou S, Zhang L, Zhang J, Cai H,
Zhu J, Huang C and Wang J: miR-518b is down-regulated, and involved
in cell proliferation and invasion by targeting Rap1b in esophageal
squamous cell carcinoma. FEBS Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang M, Yang Q, Zhang L, Zhou S, Ye W,
Yao Q, Li Z, Huang C, Wen Q and Wang J: miR-302b is a potential
molecular marker of esophageal squamous cell carcinoma and
functions as a tumor suppressor by targeting ErbB4. J Exp Clin
Cancer Res. 33:102014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou S, Ye W, Ren J, Shao Q, Qi Y, Liang J
and Zhang M: MicroRNA-381 increases radiosensitivity in esophageal
squamous cell carcinoma. Am J Cancer Res. 5:267–277.
2014.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ciechanowicz SJ and Ma D: Anaesthesia for
oncological surgery-can it really influence cancer recurrence?
Anaesthesia. 71:127–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santamaria LB, Schifilliti D, La Torre D
and Fodale V: Drugs of anaesthesia and cancer. Surg Oncol.
19:63–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tai YH, Wu HL, Chang WK, Tsou MY, Chen HH
and Chang KY: Intraoperative fentanyl consumption does not impact
cancer recurrence or overall survival after curative colorectal
cancer resection. Sci Rep. 7:108162017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu
DT, Chen DT and Ying SY: Mir-302 reprograms human skin cancer cells
into a pluripotent ES-cell-like state. RNA. 14:2115–2124. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Yao J, Shi X, Hu L, Li Z, Song T
and Huang C: MicroRNA-302b suppresses cell proliferation by
targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.
BMC Cancer. 13:4482013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Yao J, Zhang X, Guo B, Le X,
Cubberly M, Li Z, Nan K, Song T and Huang C: miRNA-302b suppresses
human hepatocellular carcinoma by targeting AKT2. Mol Cancer Res.
12:190–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Hu H, Song L, Cai L, Wei R and
Jin W: Epirubicin-mediated expression of miR-302b is involved in
osteosarcoma apoptosis and cell cycle regulation. Toxicol Lett.
222:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen PH, Shih CM, Chang WC, Cheng CH, Lin
CW, Ho KH, Su PC and Chen KC: MicroRNA-302b-inhibited E2F3
transcription factor is related to all trans retinoic acid-induced
glioma cell apoptosis. J Neurochem. 131:731–742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai D, He K, Chang S, Tong D and Huang C:
MicroRNA-302b Enhances the Sensitivity of Hepatocellular Carcinoma
Cell Lines to 5-FU via Targeting Mcl-1 and DPYD. Int J Mol Sci.
16:23668–23682. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cataldo A, Cheung DG, Balsari A, Tagliabue
E, Coppola V, Iorio MV, Palmieri D and Croce CM: miR-302b enhances
breast cancer cell sensitivity to cisplatin by regulating E2F1 and
the cellular DNA damage response. Oncotarget. 7:786–797. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L, Ma J, Han Y, Liu J, Zhou W, Hong
L and Fan D: Targeted therapy in esophageal cancer. Expert Rev
Gastroenterol Hepatol. 10:595–604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu S, Kitayama J, Yamashita H, Souma D and
Nagawa H: Nuclear translocation of HER-4/c-erbB-4 is significantly
correlated with prognosis of esophageal squamous cell carcinoma. J
Surg Oncol. 97:44–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao K, Chen BJ and Chen ZG: ErbB4 as a
potential molecular target in the treatment of esophageal squamous
cell cancers. ScientificWorldJournal. 2014:1241052014. View Article : Google Scholar : PubMed/NCBI
|
